Tezepelumab Is The First Biologic To Significantly Reduce Exacerbations In Broad Population Of Patients With Severe, Uncontrolled Asthma Biotech Investing
HempFusion Wellness Announces Broadening of Share Liquidity With DTC Full-Service Eligibility Biotech Investing
Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® in Combination with Cabometyx® as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma Biotech Investing
Allergan, an AbbVie Company, Submits New Drug Application for Investigational AGN-190584 for the Treatment of Presbyopia Biotech Investing
HUMIRA® Receives FDA Approval to Treat Pediatric Patients Living with Moderately to Severely Active Ulcerative Colitis Biotech Investing
